Acepodia, Inc. (6976.TWO)

TWD 15.4

(-16.08%)

Revenue Summary of Acepodia, Inc.

  • Acepodia, Inc.'s latest annual revenue in 2023 was 16.59 Million TWD , down 0.0% from previous year.
  • Acepodia, Inc.'s latest quarterly revenue in 2024 Q2 was 155.5 Thousand TWD , down 0.0% from previous quarter.
  • Acepodia, Inc. reported a annual revenue of - TWD in annual revenue 2022, down 0.0% from previous year.
  • Acepodia, Inc. reported a annual revenue of - TWD in annual revenue 2021, down 0.0% from previous year.
  • Acepodia, Inc. reported a quarterly revenue of 155.5 Thousand TWD for 2024 Q1, down -99.06% from previous quarter.
  • Acepodia, Inc. reported a quarterly revenue of 16.59 Million TWD for 2023 Q4, down 0.0% from previous quarter.

Annual Revenue Chart of Acepodia, Inc. (2023 - 2020)

Historical Annual Revenue of Acepodia, Inc. (2023 - 2020)

Year Revenue Revenue Growth
2023 16.59 Million TWD 0.0%
2022 - TWD 0.0%
2021 - TWD 0.0%
2020 - TWD 0.0%

Peer Revenue Comparison of Acepodia, Inc.

Name Revenue Revenue Difference
Anti-Microbial Savior BioteQ Co., Ltd 728 Thousand TWD -2179.258%
SYN-TECH Chem. & Pharm. Co., Ltd. 1.11 Billion TWD 98.511%
Level Biotechnology Inc. 660.61 Million TWD 97.488%
Sagittarius Life Science Corp 440.46 Million TWD 96.233%
NeoCore Technology Co., Ltd. 64.72 Million TWD 74.365%
TaiMed Biologics Inc. 491.77 Million TWD 96.626%
GlycoNex Incorporation 2.54 Million TWD -552.754%
VBI 55.85 Million TWD 70.292%
GeneReach Biotechnology Corp. 225.46 Million TWD 92.64%
Taiwan Advance Bio-Pharmaceutical Inc. 315.98 Million TWD 94.749%
SynCore Biotechnology Co.,Ltd 20.19 Million TWD 17.84%
Genomics BioSci & Tech. Co.,Ltd. 396.14 Million TWD 95.811%
Visgeneer Inc. 147.99 Million TWD 88.788%
Mycenax Biotech Inc. 652.62 Million TWD 97.457%
Sunmax Biotechnology Co., Ltd. 1.68 Billion TWD 99.018%
G&E Herbal Biotechnology Co., Ltd. 181.44 Million TWD 90.855%
Neith Corporation 39.9 Million TWD 58.417%
Medigen Vaccine Biologics Corporation 389.62 Million TWD 95.741%
TaiwanJ Pharmaceuticals Co., Ltd. 22.74 Million TWD 27.038%
Enimmune corporation 43.49 Million TWD 61.85%
TaiRx, Inc. 5.08 Million TWD -226.505%
CHO Pharma, Inc. - TWD -Infinity%
EirGenix Inc. 1.02 Billion TWD 98.377%
BioLASCO Taiwan Co., Ltd. 264.72 Million TWD 93.732%
Sunny Pharmtech Inc. 428.82 Million TWD 96.131%
Lin BioScience, Inc. - TWD -Infinity%
BioGend Therapeutics Co., Ltd. 109.9 Million TWD 84.903%
Feng Chi Biotech Corp. 180.57 Million TWD 90.811%
Bio Preventive Medicine Corp. 1.2 Million TWD -1273.593%
Lukas Biomedical Inc. 231.83 Million TWD 92.843%
RBC Bioscience Corporation 172.46 Million TWD 90.379%
BiOptic Inc. 228.26 Million TWD 92.731%
BRIM Biotechnology, Inc. 90 Thousand TWD -18336.667%
Shine-On BioMedical Co.,Ltd. 9.52 Million TWD -74.223%
Great Novel Therapeutics Biotech & Medicals 4.85 Million TWD -242.124%
Syngen Biotech Co.,Ltd. 1.83 Billion TWD 99.097%
Advagene Biopharma Co., Ltd. - TWD -Infinity%
NaviFUS Corp. 22.48 Million TWD 26.191%
Gwo Xi Stem Cell Applied Technology Co. , Ltd 141.17 Million TWD 88.247%
Sinew Pharma Inc. - TWD -Infinity%
Andros Pharmaceuticals Co.,Ltd 805 Thousand TWD -1961.242%
Greenyn Biotechnology Co., Ltd 800.51 Million TWD 97.927%
Lumosa Therapeutics Co., Ltd. 56.91 Million TWD 70.847%
AP Biosciences Inc 32.25 Million TWD 48.554%
Medigen Biotechnology Corp. 1.15 Billion TWD 98.567%
3D Global Biotech Inc. 20.63 Million TWD 19.58%
Pharmosa Biopharm Inc. 314.5 Million TWD 94.724%
Intech Biopharm Corporation 25.84 Million TWD 35.803%
Oneness Biotech Co., Ltd. 86.78 Million TWD 80.88%
Eusol Biotech Co.,Ltd. - TWD -Infinity%
TWi Biotechnology, Inc. - TWD -Infinity%
Ever Supreme Bio Technology Co., Ltd 758.39 Million TWD 97.812%
TCI GENE Inc. 333.85 Million TWD 95.03%
MegaPro Biomedical Co., Ltd 18 Thousand TWD -92083.333%
Senhwa Biosciences, Inc. 1 Million TWD -1559.3%
Taiwan Bio Therapeutics Co., Ltd 85.47 Million TWD 80.586%
NatureWise Biotech & Medicals Corporation 160.14 Million TWD 89.639%
PharmaEngine, Inc. 767.66 Million TWD 97.839%
Savior Lifetec Corporation 1.05 Billion TWD 98.42%
TaiGen Biopharmaceuticals Holdings Limited 123.13 Million TWD 86.524%
OBI Pharma, Inc. 41.54 Million TWD 60.064%
Meribank Biotech Co., Ltd 234.34 Million TWD 92.919%
Caliway Biopharmaceuticals Co., Ltd. 38.93 Million TWD 57.38%